Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Explore well-known S&P 500 index funds for retirement 2024, focusing on performance, costs, and suitability for your plan.
22,695 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
A security advisory from Ethereum L2 Taiko warns users to pull funds from Taiko-linked bridges after a state verifica...
Investors are parsing sector headlines as analysts cut targets for airlines and other cyclical stocks. This guide bre...
June 11 brought a surprising twist: Coupang’s privacy fine landed below feared levels, sending the stock higher and l...
Micron's latest quarterly results delivered a powerful reset for MU, but the stock's next move remains uncertain. Thi...
Chubb sits as a stalwart in global insurance, trading at roughly 12x earnings. This article breaks down what that mea...
Investors face a pivotal test of yield durability in BIZD and PBDC as rate dynamics and NAV trends threaten tradition...
What if chair kevin warsh just flipped the script on Fed communications? This analysis breaks down potential market r...
Non-China emerging markets have moved to the forefront of global returns in 2026, delivering double-digit gains even ...
A broad pullback in the Magnificent Seven pushed the tech rally into a correction. Yet analysts say this may reflect ...
Eight leading real estate lead generation firms rise to the top in 2026, offering AI powered insights, exclusive lead...
A high-profile insider sale puts Credit Acceptance and its subprime finance niche in the spotlight. This piece breaks...